The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 2,760,550 | 403,000 | SH | SOLE | 403,000 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | PUT | 00461U955 | 1,198,750 | 175,000 | SH | Put | SOLE | 175,000 | 0 | 0 | |
ACUMEN PHARMACEUTICALS INC | COM | 00509G209 | 2,697,500 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
ADMA BIOLOGICS INC | COM | 000899104 | 9,748,379 | 2,723,011 | SH | SOLE | 2,723,011 | 0 | 0 | ||
ALIMERA SCIENCES INC | COM NEW | 016259202 | 9,095,735 | 2,934,108 | SH | SOLE | 2,934,108 | 0 | 0 | ||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 9,790,357 | 534,700 | SH | SOLE | 534,700 | 0 | 0 | ||
ANAVEX LIFE SCIENCES CORP | CALL | 032797900 | 1,014,595 | 154,900 | SH | Call | SOLE | 154,900 | 0 | 0 | |
ANAVEX LIFE SCIENCES CORP | PUT | 032797950 | 1,014,595 | 154,900 | SH | Put | SOLE | 154,900 | 0 | 0 | |
APELLIS PHARMACEUTICALS INC | PUT | 03753U956 | 3,804,000 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
ARS PHARMACEUTICALS INC | PUT | 82835W958 | 378,000 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 10,049,276 | 1,347,088 | SH | SOLE | 1,347,088 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 6,429,880 | 92,000 | SH | SOLE | 92,000 | 0 | 0 | ||
BIOHAVEN LTD | COM | G1110E107 | 7,464,870 | 287,000 | SH | SOLE | 287,000 | 0 | 0 | ||
BITCOIN DEPOT INC | *W EXP 06/30/202 | 09174P113 | 9,495 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
BRUUSH ORAL CARE INC | *W EXP 08/03/202 | 11750K120 | 342 | 14,423 | SH | SOLE | 14,423 | 0 | 0 | ||
CEA INDUSTRIES INC | *W EXP 02/11/202 | 86887P119 | 9,200 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
CHAVANT CAPITAL ACQUISITN CO | *W EXP 99/99/999 | G2058L111 | 4,380 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
CINGULATE INC | *W EXP 12/10/202 | 17248W113 | 44,550 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 2,291,250 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | ||
COLISEUM ACQUISITION CORP | *W EXP 08/22/202 | G2263T107 | 3,612 | 28,333 | SH | SOLE | 28,333 | 0 | 0 | ||
CONDUIT PHARMACEUTICALS INC | *W EXP 09/22/202 | 20678X114 | 4,500 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 7,791,880 | 262,000 | SH | SOLE | 262,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 11,928,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
DIAMEDICA THERAPEUTICS INC | COM NEW | 25253X207 | 1,279,680 | 496,000 | SH | SOLE | 496,000 | 0 | 0 | ||
DIGITAL HEALTH ACQUISITION C | *W EXP 11/02/202 | 253893119 | 3,315 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
DIRECT DIGITAL HOLDINGS INC | *W EXP 02/15/202 | 25461T113 | 108,018 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
DOUBLEDOWN INTERACTIVE CO LT | ADS | 25862B109 | 516,228 | 60,876 | SH | SOLE | 60,876 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 2,822,400 | 315,000 | SH | SOLE | 315,000 | 0 | 0 | ||
FAT BRANDS INC | *W EXP 07/16/202 | 30258N121 | 974,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
GRI BIO INC | COM | 3622AW106 | 808,337 | 521,508 | SH | SOLE | 521,508 | 0 | 0 | ||
HARBOR CUSTOM DEVELOPMENT IN | *W EXP 05/09/202 | 41150T116 | 4,500 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
HARBOR CUSTOM DEVELOPMENT IN | *W EXP 10/07/202 | 41150T124 | 6,435 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 3,834,090 | 117,000 | SH | SOLE | 117,000 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 11,505,750 | 725,000 | SH | SOLE | 725,000 | 0 | 0 | ||
IMMUNOVANT INC | PUT | 45258J952 | 11,517,000 | 300,000 | SH | Put | SOLE | 300,000 | 0 | 0 | |
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 1,458,520 | 28,000 | SH | SOLE | 28,000 | 0 | 0 | ||
JASPER THERAPEUTICS INC | COM | 471871103 | 2,007,600 | 2,868,000 | SH | SOLE | 2,868,000 | 0 | 0 | ||
JEFFS BRANDS LTD | *W EXP 08/26/202 | M61472110 | 21,394 | 480,770 | SH | SOLE | 480,770 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 5,749,060 | 34,000 | SH | SOLE | 34,000 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 991,600 | 740,000 | SH | SOLE | 740,000 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 1,006,516 | 125,033 | SH | SOLE | 125,033 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 1,345,103 | 1,059,136 | SH | SOLE | 1,059,136 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 5,016,000 | 88,000 | SH | SOLE | 88,000 | 0 | 0 | ||
NEXALIN TECHNOLOGY INC | *W EXP 09/15/202 | 65345B110 | 2,625 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
NEXGEL INC | *W EXP 12/01/202 | 65344E115 | 76,500 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
NLS PHARMACEUTICS LTD | *W EXP 02/02/202 | H57830111 | 21,040 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
NOCTURNE ACQUISITION CORP | RIGHT 12/26/2025 | G6580S106 | 78,250 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 4,137,250 | 335,000 | SH | SOLE | 335,000 | 0 | 0 | ||
ONFOLIO HOLDINGS INC | *W EXP 01/02/202 | 68277K124 | 26,680 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
OPY ACQUISITION CORP I | *W EXP 09/22/202 | 671005114 | 1,385 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 2,533,171 | 418,706 | SH | SOLE | 418,706 | 0 | 0 | ||
PEPPERLIME HEALTH ACQUSTN CO | *W EXP 10/01/202 | G70021111 | 26,093 | 367,500 | SH | SOLE | 367,500 | 0 | 0 | ||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 2,281,400 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 1,111,500 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
PROSOMNUS INC | *W EXP 04/20/202 | 50535E116 | 10,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
RELATIVITY ACQUISITION CORP | *W EXP 12/15/202 | 75944B114 | 0 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
REPLIMUNE GROUP INC | COM | 76029N106 | 2,652,050 | 155,000 | SH | SOLE | 155,000 | 0 | 0 | ||
SADOT GROUP INC | COM | 627333107 | 604,819 | 865,263 | SH | SOLE | 865,263 | 0 | 0 | ||
SAGIMET BIOSCIENCES INC | COM SER A | 786700104 | 4,251,993 | 483,181 | SH | SOLE | 483,181 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 3,551,746 | 29,300 | SH | SOLE | 29,300 | 0 | 0 | ||
SELINA HOSPITALITY PLC | *W EXP 10/27/202 | G8059B119 | 1,420 | 101,439 | SH | SOLE | 101,439 | 0 | 0 | ||
SNOW LAKE RES LTD | COM | 83336J208 | 289,587 | 219,384 | SH | SOLE | 219,384 | 0 | 0 | ||
SOLENO THERAPEUTICS INC | COM | 834203309 | 1,389,360 | 47,081 | SH | SOLE | 47,081 | 0 | 0 | ||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 7,815,100 | 155,000 | SH | SOLE | 155,000 | 0 | 0 | ||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 3,380 | 82,233 | SH | SOLE | 82,233 | 0 | 0 | ||
TC BIOPHARM HOLDINGS PLC | *W EXP 02/08/202 | 87807D111 | 393 | 18,823 | SH | SOLE | 18,823 | 0 | 0 | ||
TG VENTURE ACQUISITION CORP | *W EXP 08/15/202 | 87251T117 | 6,400 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | 4,574,767 | 333,681 | SH | SOLE | 333,681 | 0 | 0 | ||
WEARABLE DEVICES LTD | *W EXP 09/14/202 | M97838110 | 168,474 | 1,411,600 | SH | SOLE | 1,411,600 | 0 | 0 | ||
WESTERN ACQSTN VENTURES CORP | *W EXP 09/01/202 | 95758L115 | 3,210 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 7,788,480 | 228,000 | SH | SOLE | 228,000 | 0 | 0 | ||
XTANT MED HLDGS INC | COM NEW | 98420P308 | 9,827,798 | 8,934,362 | SH | SOLE | 8,934,362 | 0 | 0 |